The Leading eBooks Store Online 4,385,058 members ⚫ 1,459,539 ebooks

New to eBooks.com?

Learn more

Antibody-Drug Conjugates

The 21st Century Magic Bullets for Cancer

Antibody-Drug Conjugates by Jeffrey Wang
Buy this eBook
US$ 149.00
(If any tax is payable it will be calculated and shown at checkout.)

This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.

Springer International Publishing; March 2015
248 pages; ISBN 9783319130811
Read online, or download in secure PDF format
Title: Antibody-Drug Conjugates
Author: Jeffrey Wang; Wei-Chiang Shen; Jennica L. Zaro
 
  • News
  • Contents
No entry found